Bath & Body Works’ (BBWI) “Maintains” Rating Reiterated at 51job

Bath & Body Works (NYSE:BBWI – Get Rating)‘s stock had its “maintains” rating restated by research analysts at 51job in a research report issued on Monday, Benzinga reports.

Other analysts have also recently issued research reports about the company. Telsey Advisory Group reiterated an “outperform” rating and set a $52.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 23rd. TheStreet upgraded Bath & Body Works from a “d” rating to a “c” rating in a report on Thursday, May 18th. Citigroup lifted their price target on Bath & Body Works from $37.00 to $38.00 in a report on Friday, May 19th. Wells Fargo & Company lowered their price target on Bath & Body Works from $46.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday, April 10th. Finally, Piper Sandler cut Bath & Body Works from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $48.00 to $37.00 in a report on Thursday, April 20th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $46.45.

Bath & Body Works Trading Up 1.0 %

Bath & Body Works stock opened at $38.51 on Monday. The stock has a market cap of $8.81 billion, a PE ratio of 12.19, a P/E/G ratio of 1.02 and a beta of 1.70. The stock has a 50-day moving average price of $35.30 and a 200 day moving average price of $39.56. Bath & Body Works has a 52 week low of $25.75 and a 52 week high of $49.55.

Bath & Body Works (NYSE:BBWI – Get Rating) last posted its quarterly earnings data on Thursday, May 18th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.07. The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Bath & Body Works had a negative return on equity of 29.65% and a net margin of 9.67%. The firm’s quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.64 EPS. On average, equities analysts predict that Bath & Body Works will post 2.93 EPS for the current year.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, CFO Wendy C. Arlin sold 1,625 shares of the company’s stock in a transaction that occurred on Tuesday, March 28th. The stock was sold at an average price of $38.29, for a total value of $62,221.25. Following the transaction, the chief financial officer now directly owns 91,072 shares of the company’s stock, valued at approximately $3,487,146.88. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently made changes to their positions in BBWI. Cambridge Investment Research Advisors Inc. raised its position in shares of Bath & Body Works by 12.8% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 19,672 shares of the company’s stock valued at $940,000 after acquiring an additional 2,228 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Bath & Body Works by 3.9% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 34,484 shares of the company’s stock valued at $1,648,000 after acquiring an additional 1,301 shares in the last quarter. Vontobel Holding Ltd. raised its position in shares of Bath & Body Works by 253.4% during the 1st quarter. Vontobel Holding Ltd. now owns 44,967 shares of the company’s stock valued at $2,244,000 after acquiring an additional 32,242 shares in the last quarter. Candriam Luxembourg S.C.A. raised its position in shares of Bath & Body Works by 127.4% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 27,922 shares of the company’s stock valued at $1,335,000 after acquiring an additional 15,642 shares in the last quarter. Finally, Baird Financial Group Inc. raised its position in shares of Bath & Body Works by 54.3% during the 1st quarter. Baird Financial Group Inc. now owns 113,805 shares of the company’s stock valued at $5,440,000 after acquiring an additional 40,046 shares in the last quarter. 96.34% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

(Get Rating)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.